The National Prostate Cancer Audit (NPCA) published results
The National Prostate Cancer Audit (NPCA) published results from a prospective audit of men newly diagnosed with prostate cancer earlier this year. Men diagnosed with prostate cancer in England and Wales between 1st April 2016 and 31st March 2017 were included in the audit. Recommendations from the findings included increased use of transperineal prostate biopsy. The report noted that the use of transperineal biopsies had remained static over the period, despite the procedure
LDR Brachytherapy – Latest study indicates acceptable GU toxicity in patients with prostate cancer t
A new study published in the International Multidisciplinary Brachytherapy Journal entitled Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) has found that patients who underwent low dose rate brachytherapy displayed acceptable and comparable levels of genitourinary (GU) toxicity to those previously reported in U.S. patients. The findings of this study
BXTAccelyon welcomes Kalpesh Makvana to the team
The team at BXTAccelyon is delighted to welcome Kalpesh as the latest addition to its number. Kalpesh is an experienced Clinical Application Specialist, having previously worked in a similar role across the Midlands area. There he implemented a number of departmental policies and procedures, and provided ultrasound training and applications support in a number of clinical areas. Kalpesh is passionate about healthcare. As part of his Clinical Application Specialist role for BX
